The Zacks Analyst Blog Baxter International, Henry Schein and IDEXX LaboratoriesZacks Investment Research • 08/06/24
Countdown to Baxter (BAX) Q2 Earnings: A Look at Estimates Beyond Revenue and EPSZacks Investment Research • 08/01/24
Baxter to Host Second-Quarter 2024 Financial Results Conference Call for InvestorsBusiness Wire • 07/17/24
AutoNation, Baxter International And Other Big Stocks Moving Lower In Monday's Pre-Market SessionBenzinga • 07/15/24
Baxter publishes annual corporate responsibility report, highlighting continued focus on creating lasting impactBusiness Wire • 07/10/24
Reasons to Retain Baxter International (BAX) in Your Portfolio NowZacks Investment Research • 07/01/24
New Cohort Study Data Shows Baxter's Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four YearsBusiness Wire • 05/29/24
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Renovaro (NASDAQ:RENB)Benzinga • 05/21/24
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric IndicationBusiness Wire • 05/13/24
Baxter International: Shares Too Cheap, EPS Growth Ahead With A Possible SpinoffSeeking Alpha • 05/08/24